Defense Health Agency-Public Health scientist wins prestigious award for brain protection work
- Category
- Military affairs
- Source
- Defense Health Agency
At a glance
- What
- Military Affairs
- Who
- Defense Health Agency
- When
- Nov 19, 2026 at 3:56 PM UTC
Statement from Defense Health Agency, November 19. Story by Douglas Holl.
The Department of War selected neurobiologist Jeffrey Koenig for a prestigious science award, providing him a three-year, $465,000 grant. This funding will build an advanced brain-safety testing platform. By using human cells rather than live animals to screen chemical threats, the new platform will deliver a faster, more accurate way to protect service members.
Koenig, who works for the Defense Health Agency-Public Health toxicology directorate at Aberdeen Proving Ground, Maryland, was one of only 19 scholars selected in fiscal year 2026, which began in October 2025. This group received the Science, Mathematics, and Research for Transformation, or SMART, Scholarship-for-Service Program SEED innovation award. The program office notes SEED is not an acronym but represents seed funding for the work.
Funded by the National Defense Education Program, SMART is a major initiative under DOW Science, Technology, Engineering, and Mathematics. It is the largest education and workforce program in the DOW and provides merit-based scholarships to undergraduate and graduate students. Scholars commit to a service period of civilian employment with the DOW after graduation. To drive scientific advancement and readiness, the program's Innovation Awards fund work in critical technology areas to help scholars establish novel methodologies. Koenig's specific seed grant provides $155,000 annually. This includes optional mentor funding to support Michael Quinn Jr., the director of the toxicology directorate at APG.
"In short, it's an absolute honor," said Quinn. "Science and technology experts review these proposals. These experts come from multiple department agencies. Selecting Koenig puts him at the very top of early career scientists. This work gives our defense team the tools needed to protect our forces."
Shifting to modern science: The power of human cells
This approach solves a major limitation in chemical safety evaluation. Historically, testing brain safety has depended on live animal models. These tests are slow, expensive, and have limited relevance to humans. Koenig's platform shifts the focus toward modern human cells. These methods are called New Approach Methodologies, or NAMs.
"Our work uses human adult cells," said Koenig. "We reprogram them back to neural cells. This lets us see the effects of potential toxins on the early stages of human brain development."
This high-quality data lets professionals track chemical hazards with great precision, said Quinn, who explained that the toxicology team must perform tests that also meet strict national and international guidelines.
"This ensures our data is defensible and meets high standards of quality,โ said Quinn. โKoenig's new platform expands our ability to assess toxic impacts early and provides vital information to shape future safety standards."
Clinical impacts: Preventing silent brain deficits
Koenigโs work will address a critical force health protection challenge. Service members routinely encounter compounds during operations and deployments, but many of these chemicals have unknown risks to brain health. These brain hazards are especially insidious. Unlike physical trauma, exposures to these chemicals rarely produce immediate symptoms.
"The developing nervous system is uniquely sensitive to chemical insults," said Koenig. "Subtle disruption during early brain development can cause lasting structural and functional deficits. These deficits are not apparent until years after the exposure."
The latent effects of these toxins can manifest years down the road, said Koenig. Because of this, tracing the root cause is exceptionally difficult. A service member might experience cognitive decline or motor deficits decades after exposure.
Predicting hazards before service membersโ exposure can help DOW prevent lifelong brain deficits, said Koenig. This means moving from reactive treatment to proactive prevention. It provides the evidence-based guidelines needed to advise commanders on safety and force health protection.
Strategic advantage in testing
"From a strategic perspective, these modern human-cell methods, or NAMS, speed up the testing process," said Quinn. "This ultimately helps us validate and field new equipment much faster. It enhances our operational effectiveness, strategic preparedness, and helps improve overall force readiness."
Nurturing scientific talent and mentorship
The SMART SEED program does not just provide funding for new technical work. It also emphasizes long-term talent support and mentorship in the federal workforce. For Koenig, the stable funding enables better long-term planning.
"The SMART SEED Award provides funding for both laboratory equipment and labor," said Koenig. "This funding allows me to dedicate my time and effort exclusively to the aims of this work. Additionally, the three-year timeframe enables us to plan and execute a robust effort. We are no longer hindered by year-to-year funding fluctuations."
As Koenig's mentor, Quinn views his role as bridging the academic and defense worlds. He helps Koenig align scientific studies with the daily needs of service members.
"My role is to help him identify which methodologies, tools, and problem areas are most relevant to our agencyโs mission and priorities," said Quinn. "If Iโm doing my job right, Iโll help elevate his professional reputation by connecting him and his work to our key stakeholders who will begin to recognize him as a subject matter expert in his field."
The Defense Health Agency is a Combat Support Agency, serving as a force multiplier for the joint services by optimizing lethality through warfighter medical readiness.
NOTE: The mention of any non-federal entity and/or its products is for informational purposes only, and is not to be construed or interpreted, in any manner, as federal endorsement of that non-federal entity or its products.
Source: Defense Health Agency